We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$10.6B
AUM Growth
+$1.17B
Cap. Flow
+$3.01B
Cap. Flow %
28.27%
Top 10 Hldgs %
22.3%
Holding
850
New
52
Increased
273
Reduced
342
Closed
48

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$96.9M
2
MRK icon
Merck
MRK
+$73.5M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.1M
4
ILMN icon
Illumina
ILMN
+$40.4M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$57.2M
2
IMMU
Immunomedics Inc
IMMU
+$51.7M
3
KMB icon
Kimberly-Clark
KMB
+$28.5M
4
BPMC
Blueprint Medicines
BPMC
+$26.5M
5
ANET icon
Arista Networks
ANET
+$22.7M

Sector Composition

Rank Sector Weight
1 Healthcare 35.77%
2 Technology 20.35%
3 Consumer Discretionary 9.49%
4 Communication Services 7.69%
5 Financials 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEM icon
176
Newmont
NEM
$94.9B
$14.1M 0.13%
222,488
-40,803
-15% -$2.66M
CHTR icon
177
Charter Communications
CHTR
$16.7B
$13.9M 0.13%
22,294
-2,313
-9% -$1.36M
CERN
178
DELISTED
Cerner Corp
CERN
$13.7M 0.13%
189,779
+35,555
+23% +$2.53M
WCN
179
Waste Connections
WCN
$43.5B
$13.3M 0.12%
128,076
+16,263
+15% +$1.63M
CBRE icon
180
CBRE Group
CBRE
$44.1B
$13.3M 0.12%
282,537
-77,294
-21% -$3.53M
AGIO icon
181
Agios Pharmaceuticals
AGIO
$2.09B
$13.2M 0.12%
+377,605
New +$16.6M
ENPH icon
182
Enphase Energy
ENPH
$4.8B
$13M 0.12%
157,945
+5,301
+3% +$355K
CHRS icon
183
Coherus Oncology
CHRS
$219M
$13M 0.12%
708,050
+41,678
+6% +$775K
FTNT icon
184
Fortinet
FTNT
$108B
$12.9M 0.12%
548,755
+128,840
+31% +$3.33M
PRU icon
185
Prudential Financial
PRU
$43B
$12.9M 0.12%
202,838
+79,001
+64% +$5.19M
VMC icon
186
Vulcan Materials
VMC
$37.8B
$12.9M 0.12%
94,950
-952
-1% -$120K
DCPH
187
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$12.8M 0.12%
249,519
-2,196
-0.9% -$108K
ACAD icon
188
Acadia Pharmaceuticals
ACAD
$4.44B
$12.7M 0.12%
309,000
+70,000
+29% +$3.02M
CCI icon
189
Crown Castle
CCI
$33.6B
$12.6M 0.12%
75,499
-234
-0.3% -$38.6K
AZTA icon
190
Azenta
AZTA
$1.31B
$12.5M 0.12%
270,525
-104,262
-28% -$5.05M
XP icon
191
XP
XP
$8.44B
$12.5M 0.12%
298,800
-114,200
-28% -$5.22M
AFYA icon
192
Afya
AFYA
$1.33B
$12.4M 0.12%
456,600
-82,400
-15% -$2.07M
SPY icon
193
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$12.3M 0.12%
2,809,600
+1,100
+0% +$365K
ACIA
194
DELISTED
Acacia Communications Inc
ACIA
$12.1M 0.11%
180,151
+109,810
+156% +$7.45M
CEVA icon
195
CEVA Inc
CEVA
$867M
$12.1M 0.11%
307,386
-4,508
-1% -$179K
FMTX
196
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$12.1M 0.11%
+242,582
New +$9.8M
IONS icon
197
Ionis Pharmaceuticals
IONS
$9.11B
$12M 0.11%
253,700
– –
CVS icon
198
CVS Health
CVS
$138B
$12M 0.11%
206,058
+32,681
+19% +$2.03M
MCD icon
199
McDonald's
MCD
$193B
$12M 0.11%
54,771
-13,285
-20% -$2.73M
AMT icon
200
American Tower
AMT
$82.1B
$12M 0.11%
49,629
-19,782
-28% -$5.02M
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2020 Portfolio in Review

As of Q3 2020, Candriam SCA held 850 positions worth $10.6B, up 12% from $9.47B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA deployed $3.01B of net new capital in Q3 2020, opening 52 new positions and adding to 273 existing holdings. Its largest new stake was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $57.2M trimmed.

  • Candriam SCA's largest Q3 2020 buy was VIVINT SOLAR, INC.: 840,936 shares worth $35.6M.
  • Candriam SCA added most to Amgen in Q3 2020, an estimated $96.9M increase.
  • Candriam SCA's biggest Q3 2020 reduction was Apple, cutting an estimated $57.2M.
  • Candriam SCA fully exited G1 Therapeutics, Inc. Common Stock in Q3 2020, selling an estimated $21.1M.
  • Candriam SCA's ten largest holdings make up 22% of its $10.6B portfolio in Q3 2020.
  • Candriam SCA opened 52 new positions and closed 48 in Q3 2020.
  • Candriam SCA's portfolio value rose 12% quarter-over-quarter to $10.6B.

Based on Candriam SCA's 13F filing for Q3 2020, filed 19 Oct 2020.